Th1/Th2 cells in inflammatory disease states: therapeutic implications

Inflammation is initiated as a protective response by the host, but can often result in systemic pathology. Among cells of the immune system, T lymphocytes play a major role in the inflammatory response. T cell inflammation is characterised histologically by an infiltration of mononuclear cells. Key...

Full description

Saved in:

Bibliographic Details
Published in:	Expert opinion on biological therapy Vol. 4; no. 12; p. 1887
Main Authors:	Moss, Ronald B, Moll, Thomas, El-Kalay, Mohammad, Kohne, Connie, Soo Hoo, William, Encinas, Jeffrey, Carlo, Dennis J
Format:	Journal Article
Language:	English
Published:	England 01-12-2004
Subjects:	Animals Anti-Inflammatory Agents - immunology Anti-Inflammatory Agents - therapeutic use Autoimmune Diseases - drug therapy Autoimmune Diseases - immunology Histocompatibility Antigens Class II - immunology Humans Inflammation - drug therapy Inflammation - immunology Th1 Cells - immunology Th2 Cells - immunology
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Inflammation is initiated as a protective response by the host, but can often result in systemic pathology. Among cells of the immune system, T lymphocytes play a major role in the inflammatory response. T cell inflammation is characterised histologically by an infiltration of mononuclear cells. Key regulators of this response are a subset of T lymphocytes called T helper (Th) cells. These cells secrete soluble mediators called cytokines, which orchestrate the immune response. The appropriate regulation of Th cell immunity is critical in the control and prevention of diverse disease states. This review will focus on the role of Th cells in the inflammatory process involved in allergic disease, diabetes, infectious disease, rheumatoid arthritis, heart disease, multiple sclerosis and cancer. In the area of autoimmunity, in particular, a basic understanding of Th cells and cytokines has contributed to the development of clinically efficacious biological agents. This review also examines current and novel treatment strategies under investigation at present that regulate Th cell immunity, which may result in better treatments for immune-mediated diseases.
ISSN:	1744-7682
DOI:	10.1517/14712598.4.12.1887